We are live on ! Find out more
ACRS icon

Aclaris Therapeutics
ACRS

102 hedge funds and large institutions have $703M invested in Aclaris Therapeutics in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 39 increasing their positions, 33 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 33

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

5% less capital invested

Capital invested by funds: $737M → $703M (-$33.3M)

9% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 22

2% less funds holding

Funds holding: 104 → 102 (-2)

13.9% less ownership

Funds ownership: 106.29% → 92.38% (-14%)

99% less call options, than puts

Call options by funds: $20K | Put options by funds: $1.49M

Holders
102
Holders Change
-2
Holders Change %
-1.92%
% of All Funds
2.31%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
20
Increased
39
Reduced
33
Closed
22
Calls
$20K
Puts
$1.49M
Net Calls
-$1.47M
Net Calls Change
-$5.35M

Top Buyers

1
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$24.6M
2
DM
Deerfield Management
New York
+$16M
3
Franklin Resources
Franklin Resources
California
+$13.8M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$12.5M
5
BlackRock
BlackRock
New York
+$11.8M

Top Sellers

1
EAM
Eagle Asset Management
Florida
-$36.4M
2
VC
Vivo Capital
California
-$29.5M
3
PC
PointState Capital
New York
-$17.7M
4
NC
Nexthera Capital
New York
-$10.7M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$8.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
51
Teachers Advisors
New York
$1.04M +$79.7K +3,273 +8%
Swiss National Bank
52
Swiss National Bank
Switzerland
$969K – – –
California State Teachers Retirement System (CalSTRS)
53
California State Teachers Retirement System (CalSTRS)
California
$904K +$14.3K +587 +2%
AA
54
ALPS Advisors
Colorado
$843K +$113K +4,626 +16%
Lazard Asset Management
55
Lazard Asset Management
New York
$811K -$338K -13,900 -30%
CS
56
Credit Suisse
Switzerland
$759K +$148K +6,086 +25%
CCM
57
Cadence Capital Management
Massachusetts
$709K +$50.5K +2,072 +8%
MIM
58
Monashee Investment Management
Massachusetts
$658K – – –
PPA
59
Parametric Portfolio Associates
Washington
$617K +$54K +2,218 +10%
New York State Common Retirement Fund
60
New York State Common Retirement Fund
New York
$586K +$53.6K +2,200 +10%
GIP
61
Granite Investment Partners
California
$565K +$558K +22,914 New
RhumbLine Advisers
62
RhumbLine Advisers
Massachusetts
$545K -$47.6K -1,955 -8%
ProShare Advisors
63
ProShare Advisors
Maryland
$495K +$489K +20,065 New
Squarepoint
64
Squarepoint
New York
$484K +$478K +19,616 New
AllianceBernstein
65
AllianceBernstein
Tennessee
$481K – – –
Manulife (Manufacturers Life Insurance)
66
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$452K +$17.7K +725 +4%
CC
67
Caxton Corporation
New Jersey
$444K +$190K +7,818 +77%
Dimensional Fund Advisors
68
Dimensional Fund Advisors
Texas
$388K +$383K +15,717 New
AIG
69
American International Group
New York
$386K +$52.3K +2,147 +16%
Wells Fargo
70
Wells Fargo
California
$376K -$647K -26,577 -64%
State of Wisconsin Investment Board
71
State of Wisconsin Investment Board
Wisconsin
$370K – – –
LCM
72
Landscape Capital Management
New Jersey
$307K +$304K +12,469 New
Tudor Investment Corp
73
Tudor Investment Corp
Connecticut
$303K +$299K +12,296 New
Millennium Management
74
Millennium Management
New York
$291K +$287K +11,798 New
FPC
75
Falcon Point Capital
California
$244K -$192K -7,883 -44%
1 2
3
4 5

ACRS Hedge Fund Activity: Q4 2017 in Review

102 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Aclaris Therapeutics (ACRS) for Q4 2017, worth a combined $703M — down 4.5% from $737M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of ACRS and 20 opened new positions — a net loss of 2 holders — while 33 trimmed existing stakes and 39 added.

The largest buyer was D.E. Shaw & Co, adding an estimated $24.6M. The largest seller was Eagle Asset Management, exiting entirely with an estimated $36.4M sold.

  • 102 institutional investors held Aclaris Therapeutics (ACRS) as of Q4 2017, down from 104 in Q3 2017.
  • Funds reported $703M of Aclaris Therapeutics stock for Q4 2017, down 4.5% quarter-over-quarter.
  • 20 funds opened new Aclaris Therapeutics positions in Q4 2017 and 22 closed out, a net change of -2 holders.
  • The largest Aclaris Therapeutics buyer in Q4 2017 was D.E. Shaw & Co, an estimated $24.6M added.
  • The largest Aclaris Therapeutics seller in Q4 2017 was Eagle Asset Management, an estimated $36.4M sold.

Based on aggregated 13F filings for Q4 2017.